LLMpediaThe first transparent, open encyclopedia generated by LLMs

Purdue Institute for Drug Discovery

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Expansion Funnel Raw 62 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted62
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Purdue Institute for Drug Discovery
NamePurdue Institute for Drug Discovery
Established2004
TypeResearch institute
AffiliationPurdue University
CityWest Lafayette, Indiana
CountryUnited States

Purdue Institute for Drug Discovery is a translational research institute at Purdue University in West Lafayette, Indiana, focused on small-molecule therapeutics and chemical biology. The institute interacts with institutions such as National Institutes of Health, U.S. Food and Drug Administration, Eli Lilly and Company, Boehringer Ingelheim, and GlaxoSmithKline to advance lead optimization, high-throughput screening, and preclinical development. Its activities align with regional initiatives including the Indiana Biosciences Research Institute and national programs such as the National Center for Advancing Translational Sciences and the Defense Advanced Research Projects Agency.

History

Purdue's translational ambitions trace to faculty collaborations across Purdue University departments and centers including the Weldon School of Biomedical Engineering, College of Pharmacy, and Department of Chemistry, with early partnerships involving Eli Lilly and Company and the Indiana University School of Medicine. The institute was formed amid national priorities set by agencies like the National Institutes of Health and the National Science Foundation to accelerate bench-to-clinic pathways, and it built on technology transfer precedents from Purdue Research Foundation and commercialization efforts linked to the Birck Nanotechnology Center and the Discovery Park District. Leadership recruited investigators with ties to laboratories at Harvard University, Massachusetts Institute of Technology, Stanford University, University of California, San Francisco, and Yale University to establish medicinal chemistry, structural biology, and assay-development cores.

Mission and Research Focus

The institute's mission centers on discovery of small-molecule probes and drug candidates addressing targets implicated by collaborative projects with entities such as Centers for Disease Control and Prevention, American Cancer Society, Alzheimer's Association, Parkinson's Foundation, and foundations like the Bill & Melinda Gates Foundation. Research themes include enzyme inhibition, protein–protein interaction modulation, and receptor pharmacology, integrating expertise drawn from groups at Johns Hopkins University, Columbia University, University of Pennsylvania, University of Michigan, and Northwestern University. Translational goals orient toward therapeutic areas including oncology partnerships with National Cancer Institute consortia, infectious disease work coordinated with Centers for Disease Control and Prevention, and neuroscience collaborations mirrored by projects at Cold Spring Harbor Laboratory and Salk Institute for Biological Studies.

Facilities and Core Technologies

Facilities incorporate high-throughput screening platforms comparable to those at Broad Institute, and structural biology resources akin to capabilities at European Molecular Biology Laboratory and Argonne National Laboratory synchrotron collaborations. Core technologies include automated liquid handling from vendors used by Genentech, mass spectrometry systems paralleling instrumentation at Lawrence Berkeley National Laboratory, X-ray crystallography comparable to setups at Stanford Synchrotron Radiation Lightsource, NMR spectroscopy with throughput standards of Bruker facilities used by University of California, San Diego, and cheminformatics pipelines influenced by software used at Schrödinger (company), OpenEye Scientific, and Chemical Abstracts Service. Animal-model and ADME/Tox capacities align with practices at Veterans Affairs hospitals and preclinical CROs such as Charles River Laboratories and Covance.

Notable Projects and Partnerships

Projects include lead-discovery campaigns targeting kinases and proteases that involved collaborations with Eli Lilly and Company, translational oncology programs coordinated with National Cancer Institute initiatives, and antimicrobial discovery efforts aligned with programs at Centers for Disease Control and Prevention and Wellcome Trust. Partnerships extend to industry consortia with GlaxoSmithKline, joint ventures resembling those between Pfizer and academic centers, and public–private collaborations modeled on alliances with Sanofi. Spinouts and licensing activities have paralleled commercialization outcomes seen at Moderna, Genentech, and university startups nurtured by Purdue Research Foundation and incubators like Discovery Park District.

Education and Training Programs

Training programs involve graduate and postdoctoral mentorship within Purdue University departments such as the College of Pharmacy, Weldon School of Biomedical Engineering, Department of Chemistry, and the Krannert School of Management for translational entrepreneurship. Students and fellows engage in curricula informed by pedagogy at Johns Hopkins University School of Medicine, experiential rotations modeled after programs at National Institutes of Health and professional development consistent with offerings at MIT Department of Biology. Collaborative seminars and internships connect trainees with industrial partners like Eli Lilly and Company, Boehringer Ingelheim, and contract research organizations such as Charles River Laboratories.

Funding and Administration

Funding sources comprise federal grants from National Institutes of Health, research contracts from agencies like the Defense Advanced Research Projects Agency and the National Science Foundation, philanthropic support from entities such as the Bill & Melinda Gates Foundation, and industry-sponsored research with companies including Eli Lilly and Company and Pfizer. Administrative oversight involves coordination among Purdue University leadership, the Purdue Research Foundation, and advisory boards populated by members from institutions such as Harvard Medical School, Stanford University School of Medicine, and corporate partners including GlaxoSmithKline and Merck & Co..

Category:Purdue University Category:Research institutes in the United States